Randomized trial of intensive motivational interviewing for methamphetamine dependence

Journal of Addictive Diseases

Volumn 33, Issue 3, 2014, Pages 253-265

  Polcin, Douglas L ^a   Bond, Jason ^a   Korcha, Rachael ^a   Nayak, Madhabika B ^a   Galloway, Gantt P ^b   Evans, Kristy ^a  

^a PUBLIC HEALTH INSTITUTE   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Methamphetamine; Motivational interviewing; Psychotherapy; Randomized clinical trial; Treatment dose

Indexed keywords

METHAMPHETAMINE; CENTRAL STIMULANT AGENT;

ADDICTION SEVERITY INDEX; ADULT; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GROUP THERAPY; HUMAN; INTENSIVE MOTIVATIONAL INTERVIEWING; MAJOR CLINICAL STUDY; MALE; METHAMPHETAMINE DEPENDENCE; MOTIVATIONAL INTERVIEWING; NUTRITION EDUCATION; OUTCOME ASSESSMENT; OUTPATIENT CARE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; AMBULATORY CARE; ANXIETY DISORDERS; COMPARATIVE STUDY; DEPRESSIVE DISORDER; DRUG ABUSE; LONGITUDINAL STUDY; PROCEDURES; PSYCHOLOGY; REHABILITATION; TREATMENT OUTCOME;

ADULT; AMBULATORY CARE; AMPHETAMINE-RELATED DISORDERS; ANXIETY DISORDERS; CENTRAL NERVOUS SYSTEM STIMULANTS; DEPRESSIVE DISORDER; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; METHAMPHETAMINE; MOTIVATIONAL INTERVIEWING; TREATMENT OUTCOME;

EID: 84910598117     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2014.950029     Document Type: Article

References (44)

1. Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol 2003; 71:843-61.
2. Hettema J, Steele J, Miller WR. Motivational interviewing. Annu Rev Clin Psychol 2005; 1:91-111.
3. Lundahl B, Burke BL. The effectiveness and applicability of motivational interviewing: a practice-friendly review of four meta-analyses. J Clin Psychol 2009; 65:1232-45. doi: 10.1002/jclp.20638
4. Heather N. The public health and brief interventions for excessive alcohol consumption: the British experience. Addict Behav 1996; 21:857-68.
5. Project MATCH Research Group. Matching alcoholism treatment to client heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol 1997; 58:7-29.
6. Sellman JD, Sullivan PF, Dore GM, Adamson SJ, MacEwan I. A randomized controlled trial of motivational enhancement therapy (MET) for mild to moderate alcohol dependence. J Stud Alcohol 2001; 62:389-96.
7. Bien TH, Miller WR, Tonigan JS. Brief interventions for alcohol problems: a review. Addiction 1993; 88:315-36.
8. Brown JM, Miller WR. Impact of motivational interviewing on participation and outcome in residential alcoholism treatment. Psychol Addict Behav 1993; 7:211-8.
9. Dunn C, Deroo L, Rivara FP. The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction 2001; 96:1725-42.
10. Donovan DM, Rosengren DB, Downey L, Cox GB, Sloan KL. Attrition prevention with individuals awaiting publicly funded drug treatment. Addiction 2001; 96:1149-60.
11. Miller WR, Yahne CE, Tonigan JS. Motivational interviewing in drug abuse services: a randomized trial. J Consult Clin Psychol 2003; 71:754-63.
12. Mullins SM, Suarez M, Ondersma SJ, Page MC. The impact of motivational interviewing on substance abuse treatment retention: a randomized control trial of women involved with child welfare. J Subst Abuse Treat 2004; 27:51-8.
13. Schneider RJ, Casey J, Kohn R. Motivational versus confrontational interviewing: a comparison of substance abuse assessment practices at employee assistance programs. J Behav Health Serv R 2000; 27:60-74.
14. Winhusen T, Kropp F, Babcock D, et al. Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users. J Subst Abuse Treat 2008; 35:161-73.
15. Carroll KM, Ball SA, Nich C, et al. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Depend 2006; 81:301-12.
16. Polcin DL, Galloway GP, Palmer J, MainsW. The case for high-dose motivational enhancement therapy. Subst Use Misuse 2004; 39:331-43.
17. Polcin DL, Brown M, Galloway GP. Intensive motivational enhancement therapy manual. Berkeley, CA: Alcohol Research Group, 2005.
18. Ball SA, Martino S, Nich C, et al. Site matters: multisite randomized trial of motivational enhancement therapy in community drug abuse clinics. J Consult Clin Psychol 2007; 75:556-67.
19. Galloway GP, Polcin DL, Kielstein A, Brown M, Mendelson J. A nine session manual of motivational enhancement therapy for methamphetamine dependence: adherence and efficacy. J Psychoactive Drugs 2007; Suppl 4:393-400.
20. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
21. Martino S, Ball SA, Gallon SL, et al. Motivational interviewing assessment: supervisory tools for enhancing proficiency. Salem, OR: Northwest Frontier Addiction Technology Transfer Center, Oregon Health and Science University, 2006. http://www.webcitation.org/6EDD4BNKM (accessed February 5, 2013).
22. Nuro KF, Maccarelli L, Martino S, et al. Yale Adherence and Competence Scale (YACSII) guidelines. West Haven, CT: Yale University Psychotherapy Development Center, 2005.
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Publishing, Inc., 2000.
24. Forman RF, Svikis D, Montoya ID, Blaine J. Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat 2004; 27:1-8.
25. Sobell LC, Sobell MB, Buchan G, Cleland PA, Fedoroff IC, Leo GI. The reliability of the Timeline Followback method applied to drug, cigarette, and cannabis use. In: Association for the Advancement of Behavior Therapy. New York, NY: November 21-24, 1996.
26. Cacciola JS, Alterman AI, McLellan AT, Lin Y-T, Lynch KG. Initial evidence for the reliability and validity of a "Lite" version of the Addiction Severity Index. Drug Alcohol Depend 2007; 87:297-302.
27. McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 1980; 168:26-33.
28. SPSS Inc. PASW Statistics 18. Chicago, IL: SPSS, Inc., 2009.
29. StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP, 2013.
30. Diggle PJ, Heagerty P, Liang K-Y, Zeger SL. Analysis of Longitudinal Data. 2nd ed. Oxford, UK: Oxford University Press, 2002.
31. Korcha RA, Polcin DL, Evans K, Bond JC, Galloway GP. Intensive motivational interviewing for women with concurrent alcohol problems and methamphetamine dependence. J Subst Abuse Treat 2014; 46:113-9.
32. Rawson RA, Marinelli-Casey P, Anglin MD, et al. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction 2004; 99:708-17.
33. Clifford PR, Maisto SA, Davis CM. Alcohol treatment research assessment exposure subject reactivity effects: Part 1. Alcohol use and related consequences. J Stud Alcohol Drugs 2007; 68:519-28.
34. Miller WR. Rediscovering fire: small interventions, large effects. Psychol Addict Behav 2000; 14:6-18.
35. Polcin DL, Sterling J, Brown T, Brown M, Buscemi R. Client and therapist views about intensive and standard motivational interviewing [working paper]. Emeryville, CA: Alcohol Research Group, 2014.
36. Marshall TA, Cunningham M, Guzman-Armstrong S. Dietary habits of methamphetamine users. J Am Diet Assoc 2010; 110:A44-A.
37. Polcin DL, Buscemi R, Nayak M, Korcha R, Galloway G. Gender differences in psychiatric symptoms among methamphetamine-dependent residents in sober living houses. Addict Disord Their Treat 2012; 11:53-63.
38. Cleary M, Hunt GE, Matheson S, Walter G. Psychosocial treatments for people with co-occurring severe mental illness and substance misuse: systematic review. J Adv Nurs 2009; 65:238-58.
39. Cleary M, Hunt G, Matheson S, Siegfried N, Walter G. Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev 2008:CD001088.
40. Kelly TM, Daley DC, Douaihy AB. Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav 2012; 37:11-24.
41. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, et al. Psychopathology in metham-phetamine- dependent adults 3 years after treatment. Drug Alcohol Rev 2010; 29:12-20.
42. Howard KI, Kopta SM, Krause MS, Orlinsky DE. The dose-effect relationship in psychotherapy. Am Psychol 1986; 41:159-64.
43. Seligman ME. The effectiveness of psychotherapy: The Consumer Reports study. Am Psychol 1995; 50:965-74.
44. Shadish WR, Matt GE, Navarro AM, Phillips G. The effects of psychological therapies under clinically representative conditions: a meta-analysis. Psychol Bull 2000; 126:512-29.